Yellow fever natural history

Jump to: navigation, search

Yellow fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Yellow Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Treatment

Case #1

Yellow fever natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Yellow fever natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Yellow fever natural history

CDC on Yellow fever natural history

Yellow fever natural history in the news

Blogs on Yellow fever natural history

Directions to Hospitals Treating Yellow fever

Risk calculators and risk factors for Yellow fever natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Initial symptoms of yellow fever start 3-6 days after the mosquito bite, these include sudden onset of fever, chills, severe headache, back pain, general body aches, nausea and vomiting, fatigue, and weakness. Most people improve after these initial symptoms. However, roughly 15% of people will have a brief period of hours to a day without symptoms and will then develop a more , severe form of yellow fever disease. Possible complications include coma, disseminated intravascular coagulation (DIC), kidney failure, liver failure and shock. The prognosis is good in the majority of patients, infected persons will be asymptomatic or have mild disease with complete recovery.

Natural History, Complications and Prognosis

Natural History

  • In its mildest form, yellow fever is a self-limited infection characterized by sudden onset of fever and headache without other symptoms.
  • Other patients experience an abrupt onset of a high fever (up to 104°F/40° C), chills, severe headache, generalized myalgias, lumbosacral pain, anorexia, nausea, vomiting, and dizziness.
  • The patient appears acutely ill, and examination might demonstrate bradycardia in relation to the elevated body temperature (Faget's sign).
  • The patient is usually viremic during this period, which lasts for approximately 3 days.
  • Many patients have an uneventful recovery, but in approximately 15% of infected persons, the illness recurs in more severe form within 48 hours following the viremic period.
  • After the third to sixth day of the onset of the symptoms the patient may present return of the fever, vomiting, renal failure (oliguria), jaundice, epigastric pain and hemorrhagic diathesis. The viremia terminates during this stage and the antibodies appear in the blood. The patient may evolve with multiorgan failure during this phase. Also in this stage, AST concentrations might exceed ALT, probably due to myocardial and skeletal muscle damage. Serum creatinine and bilirubin levels also rise at this stage. Hemorrhagic manifestations may include petechiae, ecchymoses, epistaxis, melena, metrorrhagia, hematuria, haematemesis, and oozing blood from the gingiva and needle-puncture sites. Laboratory studies may show thrombocytopenia, reduced fibrinogen levels, presence of fibrin split products, reduced factors II, V, VII, VIII, IX and X, which suggest a multifactorial cause for the bleeding with a consumption coagulopathy. Myocardial disfunction may be demonstrated by abnormalities in the ST-T segment in the electrocardiogram. Encephalitis is very rare.

Complications

The possible complications are:

Prognosis

  • The majority of infected persons will be asymptomatic or have mild disease with complete recovery. [2]
  • In persons who become symptomatic but recover, weakness and fatigue may last several months.
  • Among those who develop severe disease, 20% - 50% may die.
  • Those who recover from yellow fever generally have lasting immunity against subsequent infection.

References

  1. Monath TP (2001). "Yellow fever: an update". Lancet Infect Dis. 1 (1): 11–20. doi:10.1016/S1473-3099(01)00016-0. PMID 11871403.
  2. "CDC Yellow Fever Symptoms and Treatment".



Linked-in.jpg